Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 62.58%12.4B | 31.96%96.36B | -40.25%7.63B | 47.23%73.02B | -29.21%11.72B | 83.22%24.74B | 124.54%23.79B | 42.86%12.77B | 55.47%49.6B | 77.11%16.56B |
| Cost of revenue | 63.19%9.62B | 30.61%75.25B | -41.34%5.9B | 46.89%57.61B | -30.95%8.31B | 87.97%20.65B | 113.29%18.6B | 34.43%10.05B | 61.78%39.22B | 72.17%12.04B |
| Gross profit | 60.48%2.78B | 37.02%21.11B | -36.20%1.73B | 48.54%15.41B | -24.55%3.41B | 62.49%4.09B | 176.79%5.19B | 85.98%2.72B | 35.47%10.37B | 91.77%4.52B |
| Operating expense | 2.33%1.4B | 20.57%5.74B | 30.29%1.37B | 24.52%4.76B | 11.27%1.21B | 38.01%1.36B | 25.59%1.13B | 24.75%1.05B | 18.58%3.82B | 22.76%1.09B |
| Selling and administrative expenses | 2.33%1.4B | 20.57%5.74B | 30.29%1.37B | 24.52%4.76B | 11.27%1.21B | 38.01%1.36B | 25.59%1.13B | 24.75%1.05B | 18.58%3.82B | 22.76%1.09B |
| -General and administrative expense | 2.33%1.4B | 20.57%5.74B | 30.29%1.37B | 24.52%4.76B | 11.27%1.21B | 38.01%1.36B | 25.59%1.13B | 24.75%1.05B | 18.58%3.82B | 22.76%1.09B |
| Total other operating income | ---- | --22.24M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 280.79%1.38B | 44.37%15.37B | -78.25%362.03M | 62.56%10.65B | -35.95%2.2B | 78.22%2.73B | 317.12%4.06B | 169.70%1.66B | 47.75%6.55B | 133.54%3.43B |
| Net non-operating interest income (expenses) | -44.25%-514.79M | -265.34%-1.85B | -10,780.09%-356.87M | -1,680.97%-507.63M | -2,404.27%-267.61M | -1,631.12%-154.78M | -1,529.18%-81.96M | 14.69%-3.28M | -131.21%-28.5M | -761.77%-10.69M |
| Non-operating interest income | 144.72%37.78M | -45.15%44.74M | -8.64%15.44M | 185.39%81.57M | -7.96%7.42M | 131.68%26.28M | 457.38%30.99M | 365.87%16.9M | 50.60%28.58M | 21.62%8.06M |
| Non-operating interest expense | 48.42%552.56M | 222.35%1.9B | 1,745.19%372.3M | 932.13%589.2M | 1,367.40%275.02M | 792.68%181.05M | 966.56%112.95M | 170.03%20.18M | 82.34%57.09M | 138.33%18.74M |
| Net investment income | -98.91%5.25M | -134.73%-232.86M | 15.94%481.04M | 495.28%670.56M | 283.53%437.66M | -131.50%-364.86M | 42.01%182.86M | 324.80%414.89M | -239.07%-169.64M | -460.11%-238.47M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 8.57M | |||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 357.87%50.96M | 99.78%-3K | -98.92%11.13M | -99.73%2.82M | 1,425.00%53K | 9.64M | -1.39M | 30,234.99%1.03B | 1.03B |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---1.04B | ---- |
| Less:Other special charges | ---- | -357.87%-50.96M | -99.78%3K | -711.87%-11.13M | -255.59%-2.82M | ---53K | ---9.64M | --1.39M | -47.00%1.82M | --1.82M |
| Other non-operating income (expenses) | -1,139.47%-86.31M | 1,010.60%64.1M | -56.25%8.3M | -91.00%5.77M | -93.69%2.49M | -148.70%-3.77M | -224.01%-11.92M | 158.33%18.98M | 64.21%64.13M | 280.91%39.43M |
| Income before tax | 60.01%791.27M | 23.76%13.4B | -76.38%494.5M | 45.33%10.83B | -44.24%2.37B | 60.71%2.21B | 275.75%4.16B | 191.47%2.09B | 62.73%7.45B | 175.56%4.25B |
| Income tax | 292.58%326.87M | 12.30%3.2B | -91.47%83.26M | 73.38%2.85B | -74.07%196.43M | 45.59%464.81M | 318.02%1.21B | 252.62%975.71M | 27.72%1.64B | 80.15%757.55M |
| Net income | 12.93%464.4M | 27.85%10.2B | -63.22%411.24M | 37.39%7.98B | -37.78%2.17B | 65.30%1.74B | 260.73%2.94B | 153.15%1.12B | 76.41%5.81B | 211.29%3.5B |
| Net income continuous operations | 12.93%464.4M | 27.85%10.2B | -63.22%411.24M | 37.39%7.98B | -37.78%2.17B | 65.30%1.74B | 260.73%2.94B | 153.15%1.12B | 76.41%5.81B | 211.29%3.5B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 12.93%464.4M | 27.85%10.2B | -63.22%411.24M | 37.39%7.98B | -37.78%2.17B | 65.30%1.74B | 260.73%2.94B | 153.15%1.12B | 76.41%5.81B | 211.29%3.5B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 12.93%464.4M | 27.85%10.2B | -63.22%411.24M | 37.39%7.98B | -37.78%2.17B | 65.30%1.74B | 260.73%2.94B | 153.15%1.12B | 76.41%5.81B | 211.29%3.5B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 12.05%12.27 | 26.83%270.75 | -63.52%10.95 | 36.05%213.47 | -38.47%58.0625 | 63.66%46.5375 | 256.57%78.855 | 150.33%30.015 | 75.51%156.9 | 209.43%94.36 |
| Diluted earnings per share | 14.03%12.11 | 25.72%263.64 | -64.08%10.62 | 34.83%209.7 | -38.34%57.6675 | 59.46%44.9325 | 253.30%77.5325 | 148.68%29.5675 | 75.64%155.53 | 209.40%93.5175 |
| Dividend per share | 0 | 28.00%80 | 0 | 66.67%62.5 | 72.73%47.5 | 0 | 50.00%15 | 0 | 76.47%37.5 | 69.23%27.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |